P414: PATIENT-DERIVED XENOGRAFT MODELS ARE THE LEADING STRATEGY TO IDENTIFY NEW AGENTS FOR PEDIATRIC ACUTE MYELOID LEUKEMIA

• Ambra Da Ros,
• Valentina Indio,
• Alberto Peloso,
• Claudia Tregnago,
• Giulia Borella,
• Maddalena Benetton,
• Giorgia Longo,
• Silvia Bresolin,
• Barbara Buldini,
• Andrea Pession,
• Franco Locatelli,
• Martina Pigazzi

Affiliations

Ambra Da Ros

1 University of Padova, Department of Women’s and Children’s Health, Padova, Italy

Valentina Indio

2 University of Bologna, Department of Veterinary Medical Science, Bologna, Italy

Alberto Peloso

1 University of Padova, Department of Women’s and Children’s Health, Padova, Italy

Claudia Tregnago

1 University of Padova, Department of Women’s and Children’s Health, Padova, Italy

Giulia Borella

1 University of Padova, Department of Women’s and Children’s Health, Padova, Italy

Maddalena Benetton

1 University of Padova, Department of Women’s and Children’s Health, Padova, Italy

Giorgia Longo

1 University of Padova, Department of Women’s and Children’s Health, Padova, Italy

Silvia Bresolin

1 University of Padova, Department of Women’s and Children’s Health, Padova, Italy

Barbara Buldini

1 University of Padova, Department of Women’s and Children’s Health, Padova, Italy

Andrea Pession

4 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Pediatric Unit, Bologna, Italy

Franco Locatelli

5 Bambino Gesù Children’s Hospital, Catholic University of the Sacred Heart, Department of Pediatric Hematology and Oncology, Rome, Italy

Martina Pigazzi

1 University of Padova, Department of Women’s and Children’s Health, Padova, Italy